Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population

26 Nov 2024

Abstract excerpt

INTRODUCTION: Barrett esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). We aimed to assess performance, safety, and tolerability of the EsoGuard (EG) assay on samples collected nonendoscopically with the EsoCheck (EC) device (EG/EC) for BE detection in the intended-use population meeting American College of Gastroenterology guideline criteria (chronic gastroesophageal reflux disease and 3+...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Eosinophilic Esophagitis
Share to Esophageal Cancer Research and Treatment
Share to Gastroesophageal reflux and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39588974
DOI: 10.14309/ajg.0000000000003238

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening PopulationPMID 39588974Read ↗

NON-ENDOSCOPIC ESOPHAGEAL SAMPLING DEVICE AND BIOMARKER PANEL FOR DETECTION OF BARRETT’S ESOPHAGUS (BE) AND ESOPHAGEAL ADENOCARCINOMA (EAC)Semantic proximity Read ↗

Analytical Validation of a DNA Methylation Biomarker Test for Diagnosis of BE and EAC from Samples Collected Using EsoCheck®, a Non-endoscopic Esophageal Cell Collection DeviceSemantic proximity Read ↗

DNA methylation markers in esophageal cancerSemantic proximity Read ↗

Epigenetic biomarkers in esophageal cancer.Semantic proximity Read ↗

Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” eraSemantic proximity Read ↗

Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.Semantic proximity Read ↗

Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in PlasmaSemantic proximity Read ↗

Biomarkers for dysplastic Barrett's: ready for prime time?Semantic proximity Read ↗

Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's EsophagusSemantic proximity Read ↗

A multicenter prospective clinical trial reveals cell-free DNA methylation markers for early esophageal cancerSemantic proximity Read ↗

Esophageal adenocarcinoma phenotypes and risk factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.